BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8229136)

  • 1. Relation of tumor-cell ploidy to survival in children with medulloblastoma.
    Gajjar AJ; Heideman RL; Douglass EC; Kun LE; Kovnar EH; Sanford RA; Fairclough DL; Ayers D; Look AT
    J Clin Oncol; 1993 Nov; 11(11):2211-7. PubMed ID: 8229136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors in medulloblastoma, including DNA ploidy.
    Zerbini C; Gelber RD; Weinberg D; Sallan SE; Barnes P; Kupsky W; Scott RM; Tarbell NJ
    J Clin Oncol; 1993 Apr; 11(4):616-22. PubMed ID: 8478656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ploidy and proliferative index in medulloblastoma: useful prognostic factors?
    Tait DM; Eeles RA; Carter R; Ashley S; Ormerod MG
    Eur J Cancer; 1993; 29A(10):1383-7. PubMed ID: 8398263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug resistance gene expression in childhood medulloblastoma: correlation with clinical outcome and DNA ploidy in 29 patients.
    Chou PM; Reyes-Mugica M; Barquin N; Yasuda T; Tan X; Tomita T
    Pediatr Neurosurg; 1995; 23(6):283-91; discussion 291-2. PubMed ID: 8743996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-cell DNA content predicts outcome in children and adolescents with clinical group III embryonal rhabdomyosarcoma. The Intergroup Rhabdomyosarcoma Study Committee of the Children's Cancer Group and the Pediatric Oncology Group.
    Pappo AS; Crist WM; Kuttesch J; Rowe S; Ashmun RA; Maurer HM; Newton WA; Asmar L; Luo X; Shapiro DN
    J Clin Oncol; 1993 Oct; 11(10):1901-5. PubMed ID: 8410116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
    Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC
    Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric DNA analysis of medulloblastoma. Prognostic implication of aneuploidy.
    Tomita T; Yasue M; Engelhard HH; McLone DG; Gonzalez-Crussi F; Bauer KD
    Cancer; 1988 Feb; 61(4):744-9. PubMed ID: 3338037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA content and other prognostic features in childhood medulloblastoma. Proposal of a scoring system.
    Schofield DE; Yunis EJ; Geyer JR; Albright AL; Berger MS; Taylor SR
    Cancer; 1992 Mar; 69(5):1307-14. PubMed ID: 1739930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA ploidy as a prognostic factor in rhabdomyosarcoma. Analysis of 35 cases with image cytometry.
    Pohar-Marinsek Z; Bracko M; Lavrencak J; Us-Krasovec M
    Anal Quant Cytol Histol; 2003 Aug; 25(4):235-42. PubMed ID: 12961831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.
    Gajjar A; Chintagumpala M; Ashley D; Kellie S; Kun LE; Merchant TE; Woo S; Wheeler G; Ahern V; Krasin MJ; Fouladi M; Broniscer A; Krance R; Hale GA; Stewart CF; Dauser R; Sanford RA; Fuller C; Lau C; Boyett JM; Wallace D; Gilbertson RJ
    Lancet Oncol; 2006 Oct; 7(10):813-20. PubMed ID: 17012043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy.
    Bagatell R; Rumcheva P; London WB; Cohn SL; Look AT; Brodeur GM; Frantz C; Joshi V; Thorner P; Rao PV; Castleberry R; Bowman LC
    J Clin Oncol; 2005 Dec; 23(34):8819-27. PubMed ID: 16314642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of DNA ploidy and proliferative activity in childhood rhabdomyosarcoma: a retrospective analysis of patients enrolled onto the Italian Cooperative Rhabdomyosarcoma Study RMS88.
    De Zen L; Sommaggio A; d'Amore ES; Masiero L; di Montezemolo LC; Linari A; Madon E; Dominici C; Bosco S; Bisogno G; Carli M; Ninfo V; Basso G
    J Clin Oncol; 1997 Mar; 15(3):1198-205. PubMed ID: 9060564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient.
    Haffty BG; Toth M; Flynn S; Fischer D; Carter D
    J Clin Oncol; 1992 Dec; 10(12):1839-47. PubMed ID: 1453198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03).
    Gajjar A; Robinson GW; Smith KS; Lin T; Merchant TE; Chintagumpala M; Mahajan A; Su J; Bouffet E; Bartels U; Schechter T; Hassall T; Robertson T; Nicholls W; Gururangan S; Schroeder K; Sullivan M; Wheeler G; Hansford JR; Kellie SJ; McCowage G; Cohn R; Fisher MJ; Krasin MJ; Stewart CF; Broniscer A; Buchhalter I; Tatevossian RG; Orr BA; Neale G; Klimo P; Boop F; Srinivasan A; Pfister SM; Gilbertson RJ; Onar-Thomas A; Ellison DW; Northcott PA
    J Clin Oncol; 2021 Mar; 39(7):822-835. PubMed ID: 33405951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis.
    Ramaswamy V; Remke M; Bouffet E; Faria CC; Perreault S; Cho YJ; Shih DJ; Luu B; Dubuc AM; Northcott PA; Schüller U; Gururangan S; McLendon R; Bigner D; Fouladi M; Ligon KL; Pomeroy SL; Dunn S; Triscott J; Jabado N; Fontebasso A; Jones DT; Kool M; Karajannis MA; Gardner SL; Zagzag D; Nunes S; Pimentel J; Mora J; Lipp E; Walter AW; Ryzhova M; Zheludkova O; Kumirova E; Alshami J; Croul SE; Rutka JT; Hawkins C; Tabori U; Codispoti KE; Packer RJ; Pfister SM; Korshunov A; Taylor MD
    Lancet Oncol; 2013 Nov; 14(12):1200-7. PubMed ID: 24140199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA ploidy in soft tissue sarcoma: comparison of flow and image cytometry with clinical follow-up in 93 patients.
    Dreinhöfer KE; Baldetorp B; Akerman M; Fernö M; Rydholm A; Gustafson P
    Cytometry; 2002 Feb; 50(1):19-24. PubMed ID: 11857594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microvessel density and vascular endothelial growth factor expression as predictors of childrens' survival from cerebellar medulloblastoma.
    Tural S; Gercek A; Konya D; Ozgen S; Toplamoglu H; Ozek MM
    J Clin Neurosci; 2009 Sep; 16(9):1199-202. PubMed ID: 19524442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival and prognostic factors in a series of adults with medulloblastomas.
    Riffaud L; Saikali S; Leray E; Hamlat A; Haegelen C; Vauleon E; Lesimple T
    J Neurosurg; 2009 Sep; 111(3):478-87. PubMed ID: 19231932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone metastases of medulloblastoma in childhood; correlation with flow cytometric DNA analysis.
    Tomita T; Das L; Radkowski MA
    J Neurooncol; 1990 Apr; 8(2):113-20. PubMed ID: 2358845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic importance of DNA ploidy in medulloblastoma of childhood.
    Yasue M; Tomita T; Engelhard H; Gonzalez-Crussi F; McLone DG; Bauer KD
    J Neurosurg; 1989 Mar; 70(3):385-91. PubMed ID: 2915244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.